<VariationArchive VariationID="953066" VariationName="NM_005476.7(GNE):c.397_398dup (p.Glu134fs)" VariationType="Duplication" Accession="VCV000953066" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-05" DateCreated="2020-07-16" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="959505" VariationID="953066">
      <GeneList>
        <Gene Symbol="GNE" FullName="glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase" GeneID="10020" HGNC_ID="HGNC:23657" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="36214441" stop="36276978" display_start="36214441" display_stop="36276978" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="36214437" stop="36277052" display_start="36214437" display_stop="36277052" Strand="-" />
          </Location>
          <OMIM>603824</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005476.7(GNE):c.397_398dup (p.Glu134fs)</Name>
      <CanonicalSPDI>NC_000009.12:36246248:AT:ATAT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="36246245" stop="36246246" display_start="36246245" display_stop="36246246" variantLength="2" positionVCF="36246245" referenceAlleleVCF="A" alternateAlleleVCF="AAT" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="36246248" stop="36246249" display_start="36246248" display_stop="36246249" variantLength="2" positionVCF="36246248" referenceAlleleVCF="A" alternateAlleleVCF="AAT" />
      </Location>
      <ProteinChange>E134fs</ProteinChange>
      <ProteinChange>E75fs</ProteinChange>
      <ProteinChange>E165fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128227.3" sequenceAccession="NM_001128227" sequenceVersion="3" change="c.490_491dup" MANEPlusClinical="true">
            <Expression>NM_001128227.3:c.490_491dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121699.1" sequenceAccession="NP_001121699" sequenceVersion="1" change="p.Glu165fs">
            <Expression>NP_001121699.1:p.Glu165fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1197" sequenceAccession="LRG_1197">
            <Expression>LRG_1197:g.35795_35796dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1197t1" sequenceAccession="LRG_1197t1">
            <Expression>LRG_1197t1:c.490_491dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1197p1" sequenceAccession="LRG_1197p1" change="p.Glu165fs">
            <Expression>LRG_1197p1:p.Glu165fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1197t2" sequenceAccession="LRG_1197t2">
            <Expression>LRG_1197t2:c.397_398dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1197p2" sequenceAccession="LRG_1197p2" change="p.Glu134fs">
            <Expression>LRG_1197p2:p.Glu134fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.36246246_36246247dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.36246246_36246247dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.36246249_36246250dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.36246249_36246250dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008246.1" sequenceAccession="NG_008246" sequenceVersion="1" change="g.35795_35796dup">
            <Expression>NG_008246.1:g.35795_35796dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001190383.3" sequenceAccession="NM_001190383" sequenceVersion="3" change="c.397_398dup">
            <Expression>NM_001190383.3:c.397_398dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001177312.1" sequenceAccession="NP_001177312" sequenceVersion="1" change="p.Glu134fs">
            <Expression>NP_001177312.1:p.Glu134fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001190384.3" sequenceAccession="NM_001190384" sequenceVersion="3" change="c.220_221dup">
            <Expression>NM_001190384.3:c.220_221dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001177313.1" sequenceAccession="NP_001177313" sequenceVersion="1" change="p.Glu75fs">
            <Expression>NP_001177313.1:p.Glu75fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001190388.2" sequenceAccession="NM_001190388" sequenceVersion="2" change="c.220_221dup">
            <Expression>NM_001190388.2:c.220_221dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001177317.2" sequenceAccession="NP_001177317" sequenceVersion="2" change="p.Glu75fs">
            <Expression>NP_001177317.2:p.Glu75fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374797.1" sequenceAccession="NM_001374797" sequenceVersion="1" change="c.397_398dup">
            <Expression>NM_001374797.1:c.397_398dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361726.1" sequenceAccession="NP_001361726" sequenceVersion="1" change="p.Glu134fs">
            <Expression>NP_001361726.1:p.Glu134fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374798.1" sequenceAccession="NM_001374798" sequenceVersion="1" change="c.220_221dup">
            <Expression>NM_001374798.1:c.220_221dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361727.1" sequenceAccession="NP_001361727" sequenceVersion="1" change="p.Glu75fs">
            <Expression>NP_001361727.1:p.Glu75fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005476.7" sequenceAccession="NM_005476" sequenceVersion="7" change="c.397_398dup" MANESelect="true">
            <Expression>NM_005476.7:c.397_398dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005467.1" sequenceAccession="NP_005467" sequenceVersion="1" change="p.Glu134fs">
            <Expression>NP_005467.1:p.Glu134fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1829869628" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="Unknown function" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005476.7(GNE):c.397_398dup (p.Glu134fs) AND GNE myopathy" Accession="RCV001225305" Version="1">
        <ClassifiedConditionList TraitSetID="1671">
          <ClassifiedCondition DB="MedGen" ID="C1853926">GNE myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-04-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005476.7(GNE):c.397_398dup (p.Glu134fs) AND multiple conditions" Accession="RCV003770261" Version="1">
        <ClassifiedConditionList TraitSetID="10251">
          <ClassifiedCondition DB="MedGen" ID="C1853926">GNE myopathy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0342853">Sialuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-18" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-07-16" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24027297</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29480215</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1671" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3097" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nonaka myopathy</ElementValue>
                <XRef ID="Nonaka+myopathy/5252" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonaka distal myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCLUSION BODY MYOPATHY, HEREDITARY, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="600737" DB="OMIM" />
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOPATHY, DISTAL, WITH OR WITHOUT RIMMED VACUOLES</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy 2</ElementValue>
                <XRef ID="Inclusion+body+myopathy+2/3793" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IBM 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy quadriceps sparing</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GNE myopathy</ElementValue>
                <XRef ID="224171" DB="GeneTests" />
                <XRef ID="MONDO:0011603" DB="MONDO" />
                <XRef ID="602" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NM</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HIBM</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">QSM</ElementValue>
                <XRef Type="MIM" ID="600737" DB="OMIM" />
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IBM2</ElementValue>
                <XRef Type="MIM" ID="600737" DB="OMIM" />
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">GNE-Related Myopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9493" />
                <XRef ID="9493" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GNE myopathy is a slowly progressive muscle disease that typically presents between age 20 and 40 years with bilateral foot drop caused by anterior tibialis weakness. Lower-extremity muscle involvement progresses from the anterior to the posterior compartment of the lower leg, followed by hamstrings, then hip girdle muscles, with relative sparing of the quadriceps. A wheelchair may be needed about ten to 20 years after the onset of manifestations. The upper extremities, which may be affected within five to ten years of disease onset, do not necessarily follow a distal-to-proximal progression. In advanced stages, neck and core muscles can become affected.</Attribute>
                <XRef ID="NBK1262" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301439</ID>
                <ID Source="BookShelf">NBK1262</ID>
              </Citation>
              <XRef ID="602" DB="Orphanet" />
              <XRef ID="C1853926" DB="MedGen" />
              <XRef ID="MONDO:0011603" DB="MONDO" />
              <XRef Type="MIM" ID="605820" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10251" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3728" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Sialic Acid Storage Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sialuria, French type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sialuria</ElementValue>
                <XRef ID="21151" DB="GeneTests" />
                <XRef ID="Sialuria%2C+French+type/6588" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010028" DB="MONDO" />
                <XRef ID="238051008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4865" />
                <XRef ID="4865" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3166" DB="Orphanet" />
              <XRef ID="C0342853" DB="MedGen" />
              <XRef ID="MONDO:0010028" DB="MONDO" />
              <XRef Type="MIM" ID="269921" DB="OMIM" />
            </Trait>
            <Trait ID="3097" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nonaka myopathy</ElementValue>
                <XRef ID="Nonaka+myopathy/5252" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonaka distal myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCLUSION BODY MYOPATHY, HEREDITARY, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="600737" DB="OMIM" />
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOPATHY, DISTAL, WITH OR WITHOUT RIMMED VACUOLES</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy 2</ElementValue>
                <XRef ID="Inclusion+body+myopathy+2/3793" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IBM 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy quadriceps sparing</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GNE myopathy</ElementValue>
                <XRef ID="224171" DB="GeneTests" />
                <XRef ID="MONDO:0011603" DB="MONDO" />
                <XRef ID="602" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NM</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HIBM</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">QSM</ElementValue>
                <XRef Type="MIM" ID="600737" DB="OMIM" />
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IBM2</ElementValue>
                <XRef Type="MIM" ID="600737" DB="OMIM" />
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">GNE-Related Myopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9493" />
                <XRef ID="9493" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GNE myopathy is a slowly progressive muscle disease that typically presents between age 20 and 40 years with bilateral foot drop caused by anterior tibialis weakness. Lower-extremity muscle involvement progresses from the anterior to the posterior compartment of the lower leg, followed by hamstrings, then hip girdle muscles, with relative sparing of the quadriceps. A wheelchair may be needed about ten to 20 years after the onset of manifestations. The upper extremities, which may be affected within five to ten years of disease onset, do not necessarily follow a distal-to-proximal progression. In advanced stages, neck and core muscles can become affected.</Attribute>
                <XRef ID="NBK1262" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301439</ID>
                <ID Source="BookShelf">NBK1262</ID>
              </Citation>
              <XRef ID="602" DB="Orphanet" />
              <XRef ID="C1853926" DB="MedGen" />
              <XRef ID="MONDO:0011603" DB="MONDO" />
              <XRef Type="MIM" ID="605820" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2732531" SubmissionDate="2020-07-13" DateLastUpdated="2020-07-16" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="SUB7481316" submittedAssembly="GRCh37" title="SUB7481316" />
        <ClinVarAccession Accession="SCV001335596" DateUpdated="2020-07-16" DateCreated="2020-07-16" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A heterozygous 2 base pair duplication in exon 3 of the GNE gene that results in a frameshift and premature truncation of the protein 18 amino acids downstream to codon 165 was detected. The observed variant c.490_491dup(p.Glu165LeufsTer18) has not been reported in the 1000 genomes and ExAC databases. The in silico prediction of the variant is damaging by MutationTaster2. The reference codon is conserved across mammals. In summary, the variant meets our criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Indian Hindu</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">30</Age>
              <Age Type="maximum" age_unit="years">39</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina sequencing platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>DNA was used to perform targeted gene capture using a custom capture kit. Libraries were sequenced to mean &gt;80-100X coverage on Illumina sequencing platform. Sequence obtained were aligned to human references genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication.</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2020-02-25" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003198" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0025435" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003236" />
              </Trait>
              <Comment>Born of a non-consanguineous marriage, presented with clinical indications of myopathic changes in all upper limb muscles and anterior tibial muscles except for the quadriceps, increase in polyphasic (30-50%) with reduction in motor unit size and duration (3-6 msec) in right trapezius, deltoid, EDC and FDIO. EMG and nerve conduction studies suggested low amplitude motor response on right and left perineal nerves.</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001128227.3:exon 3</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">D-5147</Name>
            <Name>p.Glu165LeufsTer18</Name>
          </OtherNameList>
          <FunctionalConsequence Value="Unknown function" />
          <AttributeSet>
            <Attribute Type="HGVS">NM_001128227.3:c.490_491dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605820" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7481316</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8530399" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="7126628|MedGen:C0342853;C1833373" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004574387" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29480215</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24027297</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 953066). This premature translational stop signal has been observed in individual(s) with autosomal recessive GNE-related myopathy (PMID: 29480215). This sequence change creates a premature translational stop signal (p.Glu165Leufs*18) in the GNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNE are known to be pathogenic (PMID: 24027297).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.36246245_36246246insAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342853" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1833373" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2732531" TraitType="Finding" MappingType="XRef" MappingValue="HP:0025435" MappingRef="HP">
        <MedGen CUI="C4477095" Name="Increased circulating lactate dehydrogenase concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8530399" TraitType="Disease" MappingType="XRef" MappingValue="C0342853" MappingRef="MedGen">
        <MedGen CUI="C0342853" Name="Sialuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2732531" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003198" MappingRef="HP">
        <MedGen CUI="C0026848" Name="Myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2732531" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003236" MappingRef="HP">
        <MedGen CUI="C0241005" Name="Elevated circulating creatine kinase concentration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8530399" TraitType="Disease" MappingType="XRef" MappingValue="C1833373" MappingRef="MedGen">
        <MedGen CUI="C1853926" Name="GNE myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2732531" TraitType="Disease" MappingType="XRef" MappingValue="605820" MappingRef="OMIM">
        <MedGen CUI="C1853926" Name="GNE myopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

